Pasithea Therapeutics posts press release on PAS-004 data presentation at ESMO 2026

Reuters2026/07/21 11:03

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Pasithea posted a new press release on PAS-004 ahead of an ESMO Congress 2026 poster on its Phase 1 dose-escalation study.
The poster is scheduled for Oct. 23, 2026 in Madrid, covering safety and pharmacokinetics in MAPK pathway-driven advanced solid tumors.
The abstract will publish on the ESMO website under the congress embargo schedule.
Release: https://d1io3yog0oux5.cloudfront.net/_778f3af0f0856ee1c68f689721c93ae2/pasithea/news/2026-07-21_Pasithea_Therapeutics_Announces_Presentation_of_146.pdf

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pasithea Therapeutics Corporation published the original content used to generate this news brief on July 21, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Pasithea Therapeutics posts press release on PAS-004 data presentation at ESMO 2026

You may also like

Crypto prices